$1.83
0.1710.24%
At close: Dec 15, 4:00 PM EST
$1.93
0.15.46%
Pre-Market: 4:02 AM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Canopy Growth (CGC) stock?
You can purchase shares of Canopy Growth (NASDAQ:CGC) through any online brokerage.
Who are Canopy Growth (CGC) competitors?
Other companies in Canopy Growth’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), Zevra Therapeutics Inc (NASDAQ:ZVRA), GH Research PLC (NASDAQ:GHRS), SNDL Inc (NASDAQ:SNDL) and Bioage Labs Inc (NASDAQ:BIOA).
What is the forecast, or price target, for Canopy Growth (CGC) stock?
Canopy Growth has a consensus price target of $1.59.
What is the current price for Canopy Growth (CGC)?
The stock price for Canopy Growth (NASDAQ: CGC) is $1.93 last updated December 17, 2025 at 4:02 AM EST.
Does Canopy Growth (CGC) pay a dividend?
There are no upcoming dividends for Canopy Growth.
When is Canopy Growth (NASDAQ:CGC) reporting earnings?
Canopy Growth does not have any upcoming earnings scheduled.
Is Canopy Growth (CGC) going to split?
There is no upcoming split for Canopy Growth.
What sector and industry does Canopy Growth (CGC) operate in?
Canopy Growth is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
